Santé publique France, with support from the Ministry of Solidarity and Health, the Ministry of the Interior, the Ministry of Sports, and the Ministry of Ecological Transition, is conducting the...

Santé publique France has released the annual surveillance data on Legionnaires' disease in France for 2020, showing that the number of cases was significantly lower than in 2019, most likely due...

Santé publique France has released new data on household accidents among children under 15 in France, drawn from the EPAC survey. The results show that the situation remained stable between 2014...

In the June 2021 issue of its quarterly journal *La Santé en action*, Santé publique France publishes a special feature on the importance of scientific evidence in disease prevention and health...

Santé publique France has released new data on women’s participation in the organized breast cancer screening program. Every two years, this program invites women aged 50 to 74 to undergo a...

As of May 12, 2021, two new zoonotic diseases have been added to the list of reportable diseases: West Nile virus and tick-borne encephalitis.

Santé publique France, the Biostatistics and Bioinformatics Department of the Hospices Civils de Lyon, the Francim cancer registry network, and the National Cancer Institute have published the...

Santé publique France and the National Reference Center for Enteroviruses and Parechoviruses have released their latest update on enterovirus (EV) infections in France for 2020 and the first five...

Starting today, new indicators on vaccination coverage and variants of concern are available as open data on our Géodes mapping platform.

As part of the renewal of the network of National Reference Centers (NRCs) for the control of communicable diseases scheduled for late 2022, Santé publique France is reviewing the list of...

Access to prevention, care, and vaccination remains difficult for people in vulnerable situations. In light of these challenges and to mark World Refugee Day on June 20, 2021, Santé publique...

Given the diversity of emerging SARS-CoV-2 variants, the initial screening strategy targeting variants of concern VOC 20I/501Y.V1 (Alpha), VOC 20H/501Y.V2 (Beta), and 20J/501Y.V3 (Gamma) is...